GenSpera, Inc. announced that Santosh Kesari, MD, PhD, a board-certified neurologist and neuro-oncologist and a recognized leader in these fields, has joined the company's Scientific Advisory Board. Dr. Kesari is Chair of the Department of Translational Neuro-Oncology and Neurotherapeutics at the John Wayne Cancer Institute and Director of Neuro-Oncology at Providence Saint John's Health Center.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% |
|
0.00% | -98.04% |
1st Jan change | Capi. | |
---|---|---|
-98.04% | 3.21K | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- RBSH Stock
- News Rebus Holdings, Inc.
- Santosh Kesari Joins GenSpera, Inc.'s Scientific Advisory Board